Literature DB >> 10507491

Intestinal microsporidiosis occurring in two renal transplant recipients treated with mycophenolate mofetil.

A Guerard1, M Rabodonirina, L Cotte, O Liguory, M A Piens, S Daoud, S Picot, J L Touraine.   

Abstract

BACKGROUND: Intestinal microsporidiosis is a major cause of chronic diarrhea and malabsorption in patients with human immunodeficiency virus. Its occurrence in transplant recipients has exceptionally been reported to date.
METHODS: We report what we believe are the first two cases of intestinal microsporidiosis in renal transplant recipients. The patients were treated with mycophenolate mofetil.
RESULTS: The clinical presentation was chronic diarrhea with massive weight loss. Stool analysis revealed microsporidian spores, identified as Enterocytozoon bieneusi spores by polymerase chain reaction. The onset of this opportunistic infection in these two patients is believed to be secondary to an increase in immunosuppression after azathioprine replacement by mycophenolate mofetil. The withdrawal of mycophenolate mofetil led to clinical recovery.
CONCLUSION: The incidence of microsporidiosis will probably increase in transplant recipients treated with powerful immunosuppressants. Therefore, we recommend a systematic search for microsporidian spores in stool specimens in cases of unexplained diarrhea in these patients.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10507491     DOI: 10.1097/00007890-199909150-00017

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  19 in total

Review 1.  Molecular diagnosis of an Enterocytozoon bieneusi human genotype C infection in a moderately immunosuppressed human immunodeficiency virus seronegative liver-transplant recipient with severe chronic diarrhea.

Authors:  A Sing; K Tybus; J Heesemann; A Mathis
Journal:  J Clin Microbiol       Date:  2001-06       Impact factor: 5.948

2.  Induction of host chemotactic response by Encephalitozoon spp.

Authors:  Jeffrey Fischer; Jeffrey West; Nnenaya Agochukwu; Colby Suire; Hollie Hale-Donze
Journal:  Infect Immun       Date:  2006-12-18       Impact factor: 3.441

Review 3.  First cases of microsporidiosis in transplant recipients in Spain and review of the literature.

Authors:  A L Galván; A M Martín Sánchez; M A Pérez Valentín; N Henriques-Gil; F Izquierdo; S Fenoy; C del Aguila
Journal:  J Clin Microbiol       Date:  2011-02-16       Impact factor: 5.948

4.  Real-time PCR method for detection of Encephalitozoon intestinalis from stool specimens.

Authors:  D M Wolk; S K Schneider; N L Wengenack; L M Sloan; J E Rosenblatt
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

5.  Production and characterization of monoclonal antibodies against Enterocytozoon bieneusi purified from rhesus macaques.

Authors:  Quanshun Zhang; Inderpal Singh; Abhineet Sheoran; Xiaochuan Feng; John Nunnari; Angela Carville; Saul Tzipori
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

6.  Monoclonal antibodies against Enterocytozoon bieneusi of human origin.

Authors:  Abhineet S Sheoran; Xiaochuan Feng; Inderpal Singh; Susan Chapman-Bonofiglio; Sabrina Kitaka; Joel Hanawalt; John Nunnari; Keith Mansfield; James K Tumwine; Saul Tzipori
Journal:  Clin Diagn Lab Immunol       Date:  2005-09

7.  Evaluation of an immunofluorescent-antibody test using monoclonal antibodies directed against Enterocytozoon bieneusi and Encephalitozoon intestinalis for diagnosis of intestinal microsporidiosis in Bamako (Mali).

Authors:  O Alfa Cisse; A Ouattara; M Thellier; I Accoceberry; S Biligui; D Minta; O Doumbo; I Desportes-Livage; M A Thera; M Danis; A Datry
Journal:  J Clin Microbiol       Date:  2002-05       Impact factor: 5.948

Review 8.  Adverse gastrointestinal effects of mycophenolate mofetil: aetiology, incidence and management.

Authors:  M Behrend
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

9.  Evidence of different Enterocytozoon bieneusi genotypes in patients with and without human immunodeficiency virus infection.

Authors:  O Liguory; C Sarfati; F Derouin; J M Molina
Journal:  J Clin Microbiol       Date:  2001-07       Impact factor: 5.948

Review 10.  Clinical significance of enteric protozoa in the immunosuppressed human population.

Authors:  D Stark; J L N Barratt; S van Hal; D Marriott; J Harkness; J T Ellis
Journal:  Clin Microbiol Rev       Date:  2009-10       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.